Barclays’s IMS HEALTH HLDGS INC COM STK (DE) IMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-163,553
Closed -$5.13M 7174
2016
Q3
$5.13M Sell
163,553
-28,854
-15% -$843K 0.01% 1275
2016
Q2
$4.88M Buy
192,407
+169,224
+730% +$4.34M 0.01% 1331
2016
Q1
$602K Buy
23,183
+11,962
+107% +$297K ﹤0.01% 2991
2015
Q4
$280K Sell
11,221
-56,946
-84% -$1.59M ﹤0.01% 3645
2015
Q3
$1.98M Buy
68,167
+16,969
+33% +$521K ﹤0.01% 2138
2015
Q2
$1.54M Buy
51,198
+51,117
+63,107% +$1.48M ﹤0.01% 2465
2015
Q1
$2K Sell
81
-24
-23% -$622 ﹤0.01% 6954
2014
Q4
$3K Sell
105
-2,932
-97% -$74K ﹤0.01% 7111
2014
Q3
$79K Sell
3,037
-101
-3% -$2.72K ﹤0.01% 5523
2014
Q2
$79K Buy
+3,138
New +$75.4K ﹤0.01% 5609

Barclays's IMS Position: Q4 2016 in Review

Barclays sold out of IMS HEALTH HLDGS INC COM STK (DE) (IMS) in Q4 2016, closing a stake of 163,553 shares — an estimated $5.13M sold.

Barclays first reported a position in IMS in Q2 2014 and held it in 10 quarters. The position peaked at $5.13M in Q3 2016. 0 funds tracked by Wall St. Rank hold IMS as of Q4 2016.

  • Barclays reported no remaining IMS HEALTH HLDGS INC COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Barclays sold 163,553 IMS HEALTH HLDGS INC COM STK (DE) shares in Q4 2016, an estimated $5.13M.
  • Barclays first reported a position in IMS HEALTH HLDGS INC COM STK (DE) in Q2 2014 and held it in 10 quarters.
  • Barclays's IMS HEALTH HLDGS INC COM STK (DE) position peaked at $5.13M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held IMS HEALTH HLDGS INC COM STK (DE) as of Q4 2016.

Based on Barclays's 13F filing for Q4 2016, filed 14 Feb 2017.